Functional Dyspepsia in the Light of the Rome IV Criteria

S.M. Tkach

Abstract


The article deals with the problem of functional dyspepsia. The pathophysiology is described in detail, the diagnostic criteria of this disease are given, the aspects of treating patients with functional dyspepsia are considered. Drugs of first-line treatment in functional dyspepsia are prokinetics and proton pump inhibitors. The paper paid attention to a combined preparation containing domperidone (prokinetic) and omeprazole (proton pump inhibitor) — Omez DCR.


Keywords


functional dyspepsia; Rome criteria; treatment; omeprazole; domperidone

References


Arleen М. et al. Clinical experience and cardiovascular safety profile of domperidone therapy for nausea and vomiting // Gastroenterology. 2014; 146 (5): S268.

Camillieru M., Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia // Nat. Rev. Gastroenterol. Hepatol. 2013; 10: 187-194.

Drossman D.A. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV // Gastroenterology 2016; 150 (6): 1262-1279.

Mahadeva S., Goch K. Epidemiology of functional dyspepsia: a global perspective // World J. Gastroenterol. 2006; 12: 2661-2666.

Malfertheiner P., Megraud F., O’Morain C.A. et al. Ma­nagement of Helicobacter pylori infection — ​the Maastricht IV/Florence Consensus Report // Gut 2012; 61(5): 646-664.

Moayyedi P., Delaney B.C., Vakil N., Forman D., Talley N.J. The efficacy of proton pomp inhibitors in nonulcer dyspepsia: a systematic review and economic analysis // Gastroenterology 2004; 127: 1329-37.

Moayyedi P., Soo S., Deeks J., Delaney B., Innes M., Forman D. Pharmacological interventions for non-ulcer dyspepsia // Cochrane Database System. Rev. 2006; Oct 18: CD001960.

Palsson O.S., Van Tiburg M.A., Spiegek B.M. et al. Uninvestigated dyspepsia in the US general population results from the Rome Normative Gastrointestinal Symptoms Survey // Gastroenterology 2014; 146: S179.

Sakurai К. et al. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS) // BMC Gastroenterol. 2012 May; 1: 12-42.

Stanghellini V., Chan F., Hasler W. et al. Gastroduodenal Disorders // Gastroenterology 2016; 150 (6): 1380-1392.

Stanghellini V., Tack J. Gastroparesis: separate entity or just a part of dyspepsia? // Gut 2014; 63: 1972-1978.

Sugano K., Tack J., Kuipers E.J. et al. Kyoto global consensus report on management of Helicobacter pylori gastritis // Gut 2015; 64: 1353-1367.

Tack J., Talley N.J., Camilieri M. et al. Functional Gastroduodenal Disorders // Gastroenterology 2006; 130: 1466-1479.

Tack J., Carbone F., Holvoet L. et al. The use of pictograms improves symptom evaluation by patients with functional dyspepsia // Aliment. Pharmacol. Ther. 2014; 40: 523-530.

Tally N., Ford A. Functional dyspepsia // N. Engl. J. Med. 2015; 373: 1853-1863.

Van Marrewijk C.J., Mujakovic S., Fransen G.A.J. et al. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): A primary-care-based randomized controlled trial // Lancet 2009; 373: 215-225.

Van Roeden S.E. et al. Domperidone and the risk of sudden cardiac death // Ned. Tijdschr. Geneeskd. 2013; 157 (45): A6770.




DOI: https://doi.org/10.22141/2308-2097.4.62.2016.81097

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru